Advances in Targeting HPV Infection as Potential Alternative Prophylactic Means

dc.contributor.authorCarse, Sinead
dc.contributor.authorBergant, Martina
dc.contributor.authorSchäfer, Georgia
dc.date.accessioned2021-10-19T15:35:46Z
dc.date.available2021-10-19T15:35:46Z
dc.date.issued2021-02-23
dc.date.updated2021-02-26T14:55:10Z
dc.description.abstractInfection by oncogenic human papillomavirus (HPV) is the primary cause of cervical cancer and other anogenital cancers. The majority of cervical cancer cases occur in low- and middle- income countries (LMIC). Concurrent infection with Human Immunodeficiency Virus (HIV) further increases the risk of HPV infection and exacerbates disease onset and progression. Highly effective prophylactic vaccines do exist to combat HPV infection with the most common oncogenic types, but the accessibility to these in LMIC is severely limited due to cost, difficulties in accessing the target population, cultural issues, and maintenance of a cold chain. Alternative preventive measures against HPV infection that are more accessible and affordable are therefore also needed to control cervical cancer risk. There are several efforts in identifying such alternative prophylactics which target key molecules involved in early HPV infection events. This review summarizes the current knowledge of the initial steps in HPV infection, from host cell-surface engagement to cellular trafficking of the viral genome before arrival in the nucleus. The key molecules that can be potentially targeted are highlighted, and a discussion on their applicability as alternative preventive means against HPV infection, with a focus on LMIC, is presented.en_US
dc.identifierdoi: 10.3390/ijms22042201
dc.identifier.apacitationCarse, S., Bergant, M., & Schäfer, G. (2021). Advances in Targeting HPV Infection as Potential Alternative Prophylactic Means. <i>International Journal of Molecular Sciences</i>, 22(4), http://hdl.handle.net/11427/35274en_ZA
dc.identifier.chicagocitationCarse, Sinead, Martina Bergant, and Georgia Schäfer "Advances in Targeting HPV Infection as Potential Alternative Prophylactic Means." <i>International Journal of Molecular Sciences</i> 22, 4. (2021) http://hdl.handle.net/11427/35274en_ZA
dc.identifier.citationCarse, S., Bergant, M. & Schäfer, G. 2021. Advances in Targeting HPV Infection as Potential Alternative Prophylactic Means. <i>International Journal of Molecular Sciences.</i> 22(4) http://hdl.handle.net/11427/35274en_ZA
dc.identifier.ris TY - Journal Article AU - Carse, Sinead AU - Bergant, Martina AU - Schäfer, Georgia AB - Infection by oncogenic human papillomavirus (HPV) is the primary cause of cervical cancer and other anogenital cancers. The majority of cervical cancer cases occur in low- and middle- income countries (LMIC). Concurrent infection with Human Immunodeficiency Virus (HIV) further increases the risk of HPV infection and exacerbates disease onset and progression. Highly effective prophylactic vaccines do exist to combat HPV infection with the most common oncogenic types, but the accessibility to these in LMIC is severely limited due to cost, difficulties in accessing the target population, cultural issues, and maintenance of a cold chain. Alternative preventive measures against HPV infection that are more accessible and affordable are therefore also needed to control cervical cancer risk. There are several efforts in identifying such alternative prophylactics which target key molecules involved in early HPV infection events. This review summarizes the current knowledge of the initial steps in HPV infection, from host cell-surface engagement to cellular trafficking of the viral genome before arrival in the nucleus. The key molecules that can be potentially targeted are highlighted, and a discussion on their applicability as alternative preventive means against HPV infection, with a focus on LMIC, is presented. DA - 2021-02-23 DB - OpenUCT DP - University of Cape Town IS - 4 J1 - International Journal of Molecular Sciences KW - human papillomavirus (HPV) KW - cervical cancer KW - low- and middle- income countries (LMIC) KW - prophylactic vaccines LK - https://open.uct.ac.za PY - 2021 T1 - Advances in Targeting HPV Infection as Potential Alternative Prophylactic Means TI - Advances in Targeting HPV Infection as Potential Alternative Prophylactic Means UR - http://hdl.handle.net/11427/35274 ER - en_ZA
dc.identifier.urihttps://doi.org/10.3390/ijms22042201
dc.identifier.urihttp://hdl.handle.net/11427/35274
dc.identifier.vancouvercitationCarse S, Bergant M, Schäfer G. Advances in Targeting HPV Infection as Potential Alternative Prophylactic Means. International Journal of Molecular Sciences. 2021;22(4) http://hdl.handle.net/11427/35274.en_ZA
dc.language.isoenen_US
dc.publisher.departmentInstitute of Infectious Disease and Molecular Medicineen_US
dc.publisher.facultyFaculty of Health Sciencesen_US
dc.rights.urihttp://creativecommons.org/licenses/by-sa/4.0/en_US
dc.sourceInternational Journal of Molecular Sciencesen_US
dc.source.journalissue4en_US
dc.source.journalvolume22en_US
dc.source.urihttps://www.mdpi.com/journal/ijms
dc.subjecthuman papillomavirus (HPV)
dc.subjectcervical cancer
dc.subjectlow- and middle- income countries (LMIC)
dc.subjectprophylactic vaccines
dc.titleAdvances in Targeting HPV Infection as Potential Alternative Prophylactic Meansen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ijms-22-02201-v2.pdf
Size:
8.69 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description:
Collections